DK347784A - Forbindelse og praeparat til terapeutisk og diagnostisk anvendelse - Google Patents

Forbindelse og praeparat til terapeutisk og diagnostisk anvendelse Download PDF

Info

Publication number
DK347784A
DK347784A DK347784A DK347784A DK347784A DK 347784 A DK347784 A DK 347784A DK 347784 A DK347784 A DK 347784A DK 347784 A DK347784 A DK 347784A DK 347784 A DK347784 A DK 347784A
Authority
DK
Denmark
Prior art keywords
sub
gainacp
galnacp
therapeutical
preparations
Prior art date
Application number
DK347784A
Other languages
English (en)
Other versions
DK347784D0 (da
DK168272B1 (da
Inventor
Karl-Anders Karlsson
Alf Anton Lindberg
Original Assignee
Karlsson Karl Anders
Alf Anton Lindberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karlsson Karl Anders, Alf Anton Lindberg filed Critical Karlsson Karl Anders
Publication of DK347784D0 publication Critical patent/DK347784D0/da
Publication of DK347784A publication Critical patent/DK347784A/da
Application granted granted Critical
Publication of DK168272B1 publication Critical patent/DK168272B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/25—Shigella (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK347784A 1983-07-15 1984-07-13 Præparat til terapeutisk og diagnostisk anvendelse samt fremgangsmåde til bestemmelse af tilstedeværelse af toxin fra Shigella Dysenteriae DK168272B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8304007A SE8304007D0 (sv) 1983-07-15 1983-07-15 Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8304007 1983-07-15

Publications (3)

Publication Number Publication Date
DK347784D0 DK347784D0 (da) 1984-07-13
DK347784A true DK347784A (da) 1985-01-16
DK168272B1 DK168272B1 (da) 1994-03-07

Family

ID=20351988

Family Applications (1)

Application Number Title Priority Date Filing Date
DK347784A DK168272B1 (da) 1983-07-15 1984-07-13 Præparat til terapeutisk og diagnostisk anvendelse samt fremgangsmåde til bestemmelse af tilstedeværelse af toxin fra Shigella Dysenteriae

Country Status (9)

Country Link
US (1) US4724205A (da)
EP (1) EP0132242B1 (da)
JP (1) JPS6064927A (da)
AT (1) ATE96324T1 (da)
AU (1) AU581851B2 (da)
DE (1) DE3486236T2 (da)
DK (1) DK168272B1 (da)
FI (1) FI842815A (da)
SE (1) SE8304007D0 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
DK455088D0 (da) * 1988-08-12 1988-08-12 Symbicom Ab Syntetiske receptoranaloger
SE9003222L (sv) * 1990-10-10 1992-04-11 Jens Sandros Preparat foer profylaktiskt,terapeutiskt och diagnostiskt bruk vid infektioner
US5310542A (en) * 1991-12-31 1994-05-10 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing antiplaque agents
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
US6727061B2 (en) * 1997-02-20 2004-04-27 Cabtec, Inc. Methods for identifying species or Shigella and E. coli using operon sequence analysis
US5888750A (en) * 1997-05-30 1999-03-30 Synsorb Biotech, Inc. Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
US6541013B1 (en) 2000-07-13 2003-04-01 Idaho Research Foundation, Inc. Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide
US7135173B2 (en) * 2000-07-13 2006-11-14 Idaho Research Foundation, Inc. Antiviral activity of Shiga toxin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US3891508A (en) * 1973-06-01 1975-06-24 Joseph M Merrick Method of rapid identification of gram-negative bacteria
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0058665B1 (en) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
DK131083A (da) * 1982-03-23 1983-09-24 Svenska Sockerfabriks Ab Fremgangsmaade til fremstilling af terapeutiske eller diagnostiske praeparater
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling

Also Published As

Publication number Publication date
AU581851B2 (en) 1989-03-09
DK347784D0 (da) 1984-07-13
SE8304007D0 (sv) 1983-07-15
US4724205A (en) 1988-02-09
EP0132242A2 (en) 1985-01-23
EP0132242A3 (en) 1989-02-08
FI842815A0 (fi) 1984-07-12
DE3486236D1 (de) 1993-12-02
FI842815A (fi) 1985-01-16
JPS6064927A (ja) 1985-04-13
ATE96324T1 (de) 1993-11-15
DK168272B1 (da) 1994-03-07
DE3486236T2 (de) 1994-02-24
EP0132242B1 (en) 1993-10-27
AU3052884A (en) 1985-01-17

Similar Documents

Publication Publication Date Title
DK347784A (da) Forbindelse og praeparat til terapeutisk og diagnostisk anvendelse
NO167187C (no) Fremgangsmaate til fremstilling av et legemiddel.
FI864150A0 (fi) Kemiska foereningar.
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
EP0133170A3 (en) A compound and a composition for therapeutic or diagnostic use and a method for therapeutic treatment
IT1264563B1 (it) Composti fotocromatici e metodo per la loro preparazione
NO164546C (no) 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner, og antikonsepsjonsmidler inneholdende disse.
PT83309B (de) Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
AU578295B2 (en) Phenyl-substituted naphthyridines and their use as anti-ulcer drugs
ES8701161A1 (es) Un procedimiento para preparar derivados de piridiloxi
AU6826887A (en) 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
AU5300486A (en) Compound and compositions for therapeutic or diagnostic use and the use of such compound and composition for therapeutic treatment and isolation of shigatoxin
ATE73136T1 (de) Verfahren zur herstellung von 6alpha, 9alphadifluor-11beta, 17alpha-dihydroxy-16alpha-methyl4-pregnen-3,20-dion und dessen derivate.
JPS549267A (en) Novel polypeptides
ES8401488A1 (es) Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos.
JPS57192370A (en) 5,6-dihydro-11-alkylene-morphanthridin-6-one, manufacture and medicine containing same
TR21738A (tr) Florafenoksibenzil esterler,bunlarin hazirlanmasi ve pestisid olarak kullanimi
SU1119333A1 (ru) Гексахлорплатинаты s-метил-3-(4-метоксифенил)-5r-2-тиониа-бициклоалканов, проявляющие антифаговую активность
SG36885G (en) Androstane carbothioates
DE3265847D1 (en) Diglycidyl pteridine compounds, method for their preparation and their use in drugs with a cytostatic activity
ES8301230A1 (es) Un procedimiento para la preparacion de 1-fenil-5-amidotetrazoles.
UA11660A1 (uk) Засіб для обробки привитих саджаhців виhограду
BG49041A3 (en) Pesticide means and method for control of pests

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed